Abstracts

89 The dialatation of main pulmonary arterial measured by chest multislice computed temography predict poor long-term outcome in connective tissue disease associated pulmonary arterial hypertension

Abstract

Background Pulmonary arterial dilatation is a common manifestation of chest multislice computed temography (MSCT) in patients with pulmonary arterial hypertension (PAH). The exact clinical significance of these phenomena has not been clarified in connective tissue disease (CTD) associated PAH. We want to observe whether the dilatation of pulmonary aterial was associated with poor outcome in patients with CTD-PAH.

Methods We retrospectively investigated 140 CTD-PAH patients diagnosed by echocardiography during 2010 and 2018 at the first affiliated hospital of Nanjing Medical University. Digital scout chest MSCT information was obtained. Main pulmonary arterial (MPA), right pulmonary arterial (RPA) branch, left pulmonary arterial (lPA) branch, ascending aorta (AAO) and descending aorta (DAO) diameters were measured by professional radiologist. The ratio of MPA/AAO, MPA/DAO were also caiculated.

Results During the observational period of 3.44±0.23 years, 2 patients were died of serious infection, 1 patients was died of renal failuer and 33 patients were died of heart faliure. The time dependent receiver operating characteristic (ROC) curve suggested that MPA, PRA and LPA diameter may have the 10 year prognositic value in CTD-PAH patients, the corresponding cut-off values were MPA>37.70 mm, RPA >20.46 mm and LPA >20.20 mm. Kaplan-Meier analysis showed significant difference in the long-term prognosis between patients with MPA diameter <37.70 mm and MPA diameter 37.70 mm (Long-rank test p=0.00012) and between patients with LPA diameter <20.20 mm and LPA diameter 20.20 mm (Long-rank test p=0.0091). The multivariate analyses suggested that MPA 37.70 mm was the independent risk factor of poor outcome of CTD-PAH patients (HR: 0.28; 95% CI: 0.14–0.58 p=0.01).

Abstract 89 Table 1
|
Baseline demographic and clinical characteristics of survivors and non-survivors with 140 CTD-PAH
Abstract 89 Figure 2
Request permissionrequest permission icon
Abstract 89 Figure 2

Time-dependent ROC curve showing the 10-years prognostic value of MSCT parameters. These results suggest that MPA diameter, PRA diameter and LPA diameter may have prognositic value in CTD-PAH patients

Abstract 89 Figure 3
Request permissionrequest permission icon
Abstract 89 Figure 3

Kaplan-Meier analysis of the long-term prognosis based on MSCT parameters. (A) Kaplan-Meier analysis showed significant differences in the prognosis between the patients with MPA diameter <37.70 mm and those with MPA diameter ≥37.70mm (Long-rank test p=0.00012).

Abstract 89 Figure 3
Request permissionrequest permission icon
Abstract 89 Figure 3

(B) Kaplan-Meier analysis showed significant differences in the prognosis between the patients with LPA diameter <20.20mm and those with LPA diameter ≥ 20.20 mm (Long-rank test p=0.0091).

Abstract 89 Figure 3
Request permissionrequest permission icon
Abstract 89 Figure 3

(C) Kaplan-Meier analysis showed no significant differences in the prognosis between the patients with RPA diameter <20.46 mm and those with RPA diameter ≥ 20.46 mm (Long-rank test p=0.46).

Abstract 89 Table 3
|
Univariate and multivariate analyses for mortality
Abstract 89 Table 2
|
Area under the curve

Conclusions Main pulmonary arterial dilatation measured by MSCT was associated with the poor prognosis in patients with CTD-PAH.

Funding Source(s): None

Article metrics
Altmetric data not available for this article.
Dimensionsopen-url